LTR Pharma's Nasal Spray Treatment for Erectile Dysfunction Obtains Positive Early Results in Trial; Shares Surge 33%
LTR Pharma's Nasal Spray Treatment for Erectile Dysfunction Obtains Positive Early Results in Trial; Shares Surge 33%
LTRB药业鼻喷剂治疗勃起功能障碍在试验中获得积极的早期结果；股票价格飙涨33%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间